- Report
- August 2025
- 148 Pages
Global
From €3534EUR$3,999USD£3,061GBP
- Report
- January 2026
- 181 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- January 2026
- 185 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- May 2026
- 456 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- January 2026
- 140 Pages
Global
From €4197EUR$4,750USD£3,635GBP
- Report
- January 2026
- 160 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- August 2025
- 193 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- June 2025
- 400 Pages
Global
From €4373EUR$4,949USD£3,788GBP
- Report
- April 2026
- 277 Pages
Global
From €4109EUR$4,650USD£3,559GBP
- Report
- December 2025
- 200 Pages
Global
From €2642EUR$2,990USD£2,288GBP
- Report
- October 2025
- 146 Pages
Global
From €4330EUR$4,900USD£3,750GBP
- Report
- November 2025
- 120 Pages
Global
From €5258EUR$5,950USD£4,554GBP
- Report
- August 2025
- 199 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- August 2025
- 193 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- January 2026
- 182 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- January 2026
- 189 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- May 2026
- 370 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 484 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP

Non-invasive prenatal testing (NIPT) is a type of prenatal screening used to detect chromosomal abnormalities in a fetus. It is a safe and accurate method of testing that does not involve any risk to the mother or fetus. NIPT is typically used to detect Down syndrome, trisomy 18, and trisomy 13, as well as other chromosomal abnormalities. It is also used to determine the sex of the fetus. NIPT is becoming increasingly popular as an alternative to traditional invasive prenatal testing, such as amniocentesis and chorionic villus sampling.
NIPT is offered by a variety of diagnostic companies, including Illumina, Natera, Ariosa Diagnostics, and Sequenom. These companies provide a range of services, from laboratory testing to genetic counseling. They also offer a variety of testing options, such as single-gene tests, whole-genome sequencing, and targeted sequencing. Show Less Read more